Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.
Level 5 - mechanism / opinion, no new human data
Animal model laboratory experiment
PubMed 31255487 · doi:10.1016/j.neuron.2019.05.035
What was done
Investigators tested the Braak hypothesis of Parkinson's disease etiology by injecting pathologic α-synuclein (α-syn) preformed fibrils into the duodenal and pyloric muscularis layers of mice. They tracked the spatial and temporal spread of α-synucleinopathy (assessed by phosphorylation of serine 129 of α-syn), dopaminergic neuronal loss, and motor and non-motor behavioral deficits. They also evaluated whether truncal vagotomy or endogenous α-syn deficiency prevented pathology propagation and neurodegeneration.
What was found
The abstract reports qualitative observations without numerical data. Pathologic α-syn sequentially spread from the gut to the dorsal motor nucleus, then to the caudal hindbrain (including the locus coeruleus), and later to the basolateral amygdala, dorsal raphe nucleus, and substantia nigra pars compacta. Loss of dopaminergic neurons and behavioral symptoms followed a similar temporal course. Truncal vagotomy and α-syn deficiency completely prevented gut-to-brain spread, neurodegeneration, and behavioral deficits.
Why it matters
This study provides experimental evidence in a rodent model supporting the hypothesis that Parkinson's disease pathology can originate in the gut and ascend to the brain via the vagus nerve in an α-synuclein-dependent manner.
Limits
The study was conducted entirely in mice using direct tissue injection of synthetic preformed fibrils, which may not mimic spontaneous human pathophysiology or mucosal barrier penetration. Sample sizes, effect sizes, and quantitative metrics are not provided in the abstract.
Cited by
- supports In Parkinson's disease, alpha-synuclein pathology can propagate physically from the gut to the brain via the vagus nerve.